Search
Search Results
##search.searchResults.foundPlural##
-
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2559PDF: 1432HTML: 17258Bassan Fig.1: 192Bassan Fig.2: 299Bassan Fig.4: 182Fig.3: 335 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
1329PDF: 774HTML: 528 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
1094PDF: 765Suppl. Files: 166HTML: 216 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
3013PDF: 1306HTML: 3341 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2222PDF: 1146HTML: 15754COVER LETTER: 283 -
-
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1403PDF: 1034HTML: 361 -
Pathogen distribution, antimicrobial resistance, and mortality in febrile neutropenia among adults with hematological malignancies: a single-center cohort study
205PDF: 76Suppl. Files: 19Html: 45Html Suppl. Files: 13 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3985PDF: 1762HTML: 125 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
2538PDF: 686HTML: 393 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2698PDF: 897HTML: 1770 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4782Suppl. Files: 1305PDF: 1202Html: 357 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9670PDF: 6386HTML: 88353Fig.1b: 322Fig.1c: 335Fig.2a: 327Fig.2b: 290Fig.4: 361Fig.2c: 309Fig.3: 306Tab.1: 368Tab.2: 338Tab.3: 333Tab.4: 384Fig1a: 320 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2527PDF: 2200HTML: 280 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4483PDF: 2155HTML: 1983 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2164PDF: 898HTML: 693 -
-
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4513PDF: 1639HTML: 498 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2454PDF: 971HTML: 2038Fig 1 Rossi: 274 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1971PDF: 1291HTML: 385 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
3428PDF: 1160HTML: 360Suppl. Files: 550 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1181PDF: 803HTML: 7890 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
811PDF: 519HTML: 6300 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
917PDF: 982PDF Supp. Files: 124HTML: 276 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1553PDF: 802HTML: 1211Untitled: 245Untitled: 224Untitled: 210Untitled: 219Untitled: 229 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4772PDF: 1845HTML: 1460 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2490PDF: 1111HTML: 7733Untitled: 346Fig2: 249Fig3: 242Fig4: 273







